![]() | ![]() |
Formats:
|
||||||||||||
Copyright © 2003, Biophysical Society A Structural Model that Explains the Effects of Hyperglycemia on Collagenolysis Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; and Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts 02115 Address reprint requests to Collin Stultz, Bldg. 16-343, MIT, 77 Massachusetts Ave., Cambridge, MA 02139. Tel.: 617-694-1692; E-mail: cmstultz/at/partners.org. Received May 1, 2003; Accepted June 27, 2003. Abstract Prior investigations into the effects hyperglycemia on collagen degradation have yielded conflicting results. We present a new formalism for understanding the biochemistry of collagenolysis and the effects of hyperglycemia on collagen degradation. The analysis is based on an understanding of environments that affect the conformational stability of collagen. We suggest that collagen can exist in two distinct conformational states—a native state and a vulnerable state. Vulnerable collagen corresponds to a non-native conformation where partially unfolded regions near collagenase cleavage sites enable collagenases to efficiently degrade collagen. Theoretical calculations on collagen-like model peptides suggest that relatively short periods of hyperglycemia can alter the equilibrium distribution of states to favor vulnerable states of collagen. These data provide new insights into the mechanism of collagenolysis and resolve apparently discrepant experimental data on the effects of hyperglycemia on collagen degradation. INTRODUCTION Collagenolysis plays an important role in a number of diseases such as tumor metastasis, arthritis, and atherosclerotic heart disease (Celentano et al., 1997; McDonnell et al., 1999). In particular, rupture of mature atherosclerotic plaques, a process that depends on degradation of the protective collagen layer surrounding the plaque, is the major cause of catastrophic cardiovascular events in the developed world (Gaziano, 2001). Therefore, methods that lead to a deeper understanding of collagenolysis may result in effective therapies for unstable arterial syndromes such as myocardial infarctions. X-ray crystallographic structures of collagenlike triple-helical peptides suggest that the scissile bond that forms the collagenase cleavage site is concealed from solvent (Kramer et al., 1999; Stultz, 2002). It has been suggested that regions near collagenase cleavage sites must become exposed prior to collagenolysis for collagenases to gain access to their cleavage sites (Fields, 1991). Circular dichroism studies and hydrogen exchange experiments suggest that regions in the vicinity of collagenase cleavage sites are relatively unstable and can adopt alternate conformations in solution (Fan et al., 1993; Long et al., 1993). These data are consistent with the notion that protein flexibility plays a significant role in the process of collagen degradation. All collagen sequences contain a significant proportion of the imino acids proline and hydroxyproline (Stryer, 1988). However, an analysis of collagenase cleavage sites from a variety of different interstitial collagens reveals that the collagenase scissile bond is located immediately upstream from a region that is essentially devoid of any imino acids (Fields, 1991). We previously computed the free energy profile for the unfolding of a collagen-like triple-helical peptide, T3-785, that contains a representative imino-poor segment from type 3 collagen (Stultz, 2002) (Fig. 1 a
A number of factors will likely affect the equilibrium distribution of native and vulnerable states. Since vulnerable collagen is, in principle, degraded more efficiently than native collagen, factors that lead to the stabilization of vulnerable conformations are expected to promote collagen degradation. In particular, diabetes, which is characterized by hyperglycemia, is a major risk factor for acute cardiovascular events. Therefore, the effect of hyperglycemia on the distribution of native and vulnerable states is of particular interest. Previous studies on the effects of hyperglycemia on collagen degradation have yielded inconsistent results. Prolonged incubation of collagen with high glucose levels results in collagen fibers that are resistant to cleavage (Paul and Bailey, 1996). By contrast, collagen isolated from the Achilles tendons of rats exposed to a hyperglycemic state for a relatively brief period (28 days) is more susceptible to cleavage in vitro relative to collagen isolated from rats with normal blood glucose levels (Leung et al., 1986). In addition, collagen isolated from chick calvarias that have been exposed to high concentrations of extracellular glucose for 24 h is more readily degraded relative to collagen isolated from media free of glucose (Lien et al., 1992). More recently, it has been suggested that hyperglycemia is an independent predictor of mortality in patients who are hospitalized with a cardiovascular event (Wahab et al., 2002), even in patients without a known diagnosis of diabetes. This is consistent with the notion that the protective collagen layer surrounding the atherosclerotic plaque is more readily degraded in the presence of high glucose levels. These data suggest that perhaps paradoxically, unlike prolonged periods of glucose exposure, relatively brief periods of hyperglycemia may make collagen more susceptible to cleavage. Hyperglycemia affects collagen primarily through nonenzymatic glucosylation (glycation) (Paul and Bailey, 1996). There are two types of advanced glycation end products (AGEs)—those that form intermolecular cross-links and those that remain non-cross-linked. The effects of cross-linking AGEs on collagen have been well described (Paul and Bailey, 1996). Cross-links that form between collagen molecules hinder collagen degradation primarily by decreasing their elasticity and conformational flexibility. Typically, cross-linking AGEs are formed on the timescale of weeks to months, therefore only molecules that are exposed to high glucose levels for an extended period of time are affected by this mechanism of glycation (Aronson and Rayfield, 2002). By contrast, non-cross-linking AGEs form within days (Aronson and Rayfield, 2002). Therefore we hypothesized that the discrepancy between the reported effects of hyperglycemia on collagen can be explained by the fact that non-cross-linking AGEs alter the equilibrium distribution of states to make collagen more vulnerable to collagenolysis. In this work, we investigate the effects of non-cross-linking AGEs that form in the vicinity of collagenase cleavage sites with the aid of detailed molecular dynamics simulations. Our results support a model of collagenolysis where acute exposure to elevated environmental glucose alters the equilibrium distribution of conformational states to favor vulnerable conformations. In addition, these data demonstrate how the presence of native and vulnerable collagen conformations provide additional insights into the mechanism of collagenolysis. METHODS Construction of the initial model used in the molecular dynamics simulations Our calculations utilized the collagen-like peptide T3-785, a triple helical peptide composed of three identical peptide chains labeled A, B, and C (Kramer et al., 1999). Coordinates for the T3-785 peptide, were taken from PDB file 1bvk (Berman et al., 2000). A polar hydrogen model of the peptide was constructed with the CHARMM program (Brooks et al., 1983). All water molecules were deleted from the PDB coordinate file and a polar hydrogen model was constructed using CHARMM. The resulting model was energy minimized for 100 steps of steepest descent minimization with a distance dependent dielectric to relieve any poor contacts within the molecule. Determining the preferred conformation of glycated collagen Glycation preferentially occurs at sites containing a terminal amino group; e.g., lysine and arginine residues (Paul and Bailey, 1996). Interestingly, all known collagenase cleavage sites are located upstream from an imino-poor region that always contains an arginine residue (Fields, 1991). Therefore we focused on the effects of glycation on the central arginine located in one of the T3-785 peptide chains. Arginine can be glycated at two distinct sites (Fig. 3 a
The potential energy used for the alchemical transformation is given by Initial simulations revealed that scaling the internal bond, bond angles and dihedral angles of the CMA replicas resulted in large structural distortions and rotations about the N-CZ bond (Fig. 3 c Calculating the potential of mean force for glycated collagen The free energy simulations suggest that CMAtrans is the dominant form of glycated arginine in T3-785. Therefore, for these calculations we focused on the structure of T3-785 with the central arginine replaced with CMAtrans. We refer to the glycated form of collagen as T3-785*. The reaction region consisted of a sphere of radius 30 Å centered at the center of mass and included all residues between the 5th and the 28th residues in each chain. As in our previous work, the free energy of unfolding a single chain was computed; i.e., simulations with all three chains unfolding simultaneously led to high barriers suggesting that this was an unlikely mechanism for collagen unfolding (Stultz, 2002). The reaction region for the unfolding reaction was the radius of gyration of the Cα atoms in chain A; i.e., the chain containing CMAtrans. Windows from 17.7 Å to 20.0 Å in increments of 0.1 Å were used; i.e., a total of 24 windows. Simulations for the T3-785* peptide began with the 18.5 Å window (the value corresponding to the x-ray crystal structure) and proceeded in both the forward and reverse directions. The starting structure for each window was the final structure from the prior window. Each simulation consisted of 20 ps of equilibration followed by 20 ps of production dynamics. All atoms within the reaction region, including all three peptide chains of T3-785*, underwent full molecular dynamics without restraints and all residues outside the reaction region underwent molecular dynamics while being harmonically constrained to their crystallographic coordinates. Harmonic constraints were derived from average B-factors as previously described (Brooks and Karplus, 1989). At each window the reaction coordinate was restrained to the specified center point using a harmonic biasing potential with a force constant of 500 kcal/mol/Å2. The value of the reaction coordinate during the simulations was saved every 0.01 ps; this yielded 2000 data points per window. The potential of mean force at window i, RESULTS The structure of glycated collagen In the current formalism, vulnerable collagen is defined as conformations that contain partially unfolded imino-poor regions that are adjacent to collagenase cleavage sites (Fig. 2 Recently, a new non-cross-linking AGE, carboxymethyl-arginine, has been detected in large quantities within serum proteins of diabetic patients (Iijima et al., 2000; Odani et al., 2001). Interestingly, imino-poor regions of collagen that are adjacent to collagenase cleavage sites all contain a conserved arginine residue (Fields, 1991) and previous simulations on the accessible conformational states of a collagenlike model peptide suggest that this arginine residue plays a major role in stabilizing vulnerable conformations of collagen (Stultz, 2002). Therefore, the effect of arginine glycation on the conformational free energy landscape of collagen is of particular interest. To investigate the effect of CMA on the structure of collagen, we computed the free energy profile for the unfolding of a collagenlike triple-helical peptide, T3-785, that has this central arginine residue replaced with CMA (Kramer et al., 1999, 2001). We note that CMA is formed when one of the terminal guanidino nitrogens in the side chain of arginine is glycated (Fig. 3 a Glycation of arginine yields a glucosylamine (a Schiff base), which then undergoes an Amadori rearrangement to form an intermediate that is then subjected to nucleophilic attack from a water molecule to form CMA (Aronson and Rayfield, 2002) (Fig. 3 c A free energy component analysis suggests that, for the given simulation pathway, a significant portion of this free energy difference arises from poor steric contacts between the carboxymethyl moiety and the N-propyl group in the CMAcis structure. The van der Waals contribution to the overall free energy change favors the CMAtrans structure by approximately −11 kcal/mol. Virtually all of this contribution arises from interactions between the carboxymethyl moiety and the N-propyl moiety (Fig. 3 c The free energy landscape of glycated collagen favors vulnerable conformations To determine how glycation affects the accessible conformational states of collagen we computed the free energy for the unfolding of the T3-785 peptide with the central arginine replaced with the dominant conformation of CMA, CMAtrans. We refer to this mutated peptide as T3-785*. Unlike the free energy profile of the original peptide, T3-785 (Fig. 1 a
An analysis of representative structures from states N and V reveals the physical basis behind the different stabilities of the two conformations (Fig. 4 c DISCUSSION Collagen, the most abundant protein in mammals, plays an integral role in a number of disease processes (Stryer, 1988). Therefore significant effort has been directed at understanding the fundamental interactions involved in collagen degradation (Celentano and Frishman, 1997; McDonnell et al., 1999). Prior studies suggest that regions near collagenase cleavage sites are conformationally labile and that this lability is important for collagenolysis (Fields, 1991; Fan et al., 1993; Stultz, 2002). In this study, we investigated the effect of hyperglycemia on the conformational free energy landscape of collagen to understand mechanisms whereby hyperglycemia, and hence diabetes, may affect collagenolysis. The calculated free energy profiles suggest that glycation of the conserved arginine residue within imino-poor regions near collagenase cleavage sites, results in a shift in the equilibrium distribution of states to more vulnerable conformations. Our analysis resolves apparently discrepant data regarding the effects of glucose on collagenolysis. Long-term exposure to glucose leads to the formation of cross-linking AGEs that have well-established effects on collagen metabolism (Aronson and Rayfield, 2002). By contrast, relatively short term exposure to glucose results in the formation of non-cross-linking AGEs (Aronson and Rayfield, 2002), and the effects of such molecules on collagen degradation have not been well studied. Our data suggests that the effects of relatively short-term glucose exposure can be explained by conformational changes in regions near collagenase cleavage sites. These data are consistent with prior experimental studies that collagen exposed to high concentrations of glucose for relatively short periods of time is more susceptible to collagenolysis (Leung et al., 1986; Lien et al., 1992). These observations have implications for the pathogenesis of atherosclerosis and atherosclerotic plaque rupture. Collagen is responsible for maintaining the structural integrity of the atherosclerotic plaque, hence excessive collagenolysis often leads to plaque rupture and acute myocardial infarctions (Celentano and Frishman, 1997). Diabetes, which is characterized in part by hyperglycemia, is a known risk factor for atherosclerotic heart disease (Nesto and Libby, 2001). Our data suggests that diabetes not only promotes the progression of atherosclerosis, but that hyperglycemia can also make preexistent atherosclerotic plaques prone to rupture by making the collagen within the plaque more vulnerable to cleavage by interstitial collagenases. These data are consistent with recent observations that hyperglycemia, even in the absence of overt diabetes, is associated with a worse prognosis in patients who present with an acute cardiovascular event (Wahab et al., 2002). Until recently, the effects of post-translational modifications on the conformational free energy landscape of collagen have been under appreciated. However, glycation, in addition to other modifications, alters the charge distribution and solvent accessible surface of proteins. Therefore, it is not surprising that such modifications can significantly alter the equilibrium distribution of conformational states in flexible regions. Since conformational changes are essential to many enzymatic processes, including enzyme-substrate recognition, the equilibrium distribution of states will affect the ability of enzymes to interact with and metabolize their substrates. As such, we expect that our formalism will be a useful means to evaluate the effects of post-translational modifications on collagen as well as on a number of different proteins. Acknowledgments This work was supported by grants GM049039 and HL67246 from the National Institutes of Health. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||
Biochem Soc Trans. 1999 Aug; 27(4):734-40.
[Biochem Soc Trans. 1999]Nat Struct Biol. 1999 May; 6(5):454-7.
[Nat Struct Biol. 1999]J Mol Biol. 2002 Jun 21; 319(5):997-1003.
[J Mol Biol. 2002]J Theor Biol. 1991 Dec 21; 153(4):585-602.
[J Theor Biol. 1991]Biochemistry. 1993 Dec 7; 32(48):13299-309.
[Biochemistry. 1993]Biochemistry. 1993 Nov 2; 32(43):11688-95.
[Biochemistry. 1993]J Theor Biol. 1991 Dec 21; 153(4):585-602.
[J Theor Biol. 1991]J Mol Biol. 2002 Jun 21; 319(5):997-1003.
[J Mol Biol. 2002]Int J Biochem Cell Biol. 1996 Dec; 28(12):1297-310.
[Int J Biochem Cell Biol. 1996]Biochim Biophys Acta. 1986 Feb 19; 880(2-3):147-52.
[Biochim Biophys Acta. 1986]Exp Mol Pathol. 1992 Dec; 57(3):215-21.
[Exp Mol Pathol. 1992]J Am Coll Cardiol. 2002 Nov 20; 40(10):1748-54.
[J Am Coll Cardiol. 2002]Int J Biochem Cell Biol. 1996 Dec; 28(12):1297-310.
[Int J Biochem Cell Biol. 1996]Cardiovasc Diabetol. 2002 Apr 8; 1():1.
[Cardiovasc Diabetol. 2002]Nat Struct Biol. 1999 May; 6(5):454-7.
[Nat Struct Biol. 1999]Nucleic Acids Res. 2000 Jan 1; 28(1):235-42.
[Nucleic Acids Res. 2000]Int J Biochem Cell Biol. 1996 Dec; 28(12):1297-310.
[Int J Biochem Cell Biol. 1996]J Theor Biol. 1991 Dec 21; 153(4):585-602.
[J Theor Biol. 1991]J Mol Biol. 2002 Jun 21; 319(5):997-1003.
[J Mol Biol. 2002]J Mol Biol. 1998 Feb 6; 275(5):823-46.
[J Mol Biol. 1998]J Mol Biol. 2002 Jun 21; 319(5):997-1003.
[J Mol Biol. 2002]J Mol Biol. 1989 Jul 5; 208(1):159-81.
[J Mol Biol. 1989]Biochem J. 2000 Apr 1; 347 Pt 1():23-7.
[Biochem J. 2000]Biochem Biophys Res Commun. 2001 Aug 3; 285(5):1232-6.
[Biochem Biophys Res Commun. 2001]J Theor Biol. 1991 Dec 21; 153(4):585-602.
[J Theor Biol. 1991]J Mol Biol. 2002 Jun 21; 319(5):997-1003.
[J Mol Biol. 2002]Nat Struct Biol. 1999 May; 6(5):454-7.
[Nat Struct Biol. 1999]Cardiovasc Diabetol. 2002 Apr 8; 1():1.
[Cardiovasc Diabetol. 2002]Nature. 1985 Mar 21-27; 314(6008):235-8.
[Nature. 1985]J Clin Pharmacol. 1997 Nov; 37(11):991-1000.
[J Clin Pharmacol. 1997]Biochem Soc Trans. 1999 Aug; 27(4):734-40.
[Biochem Soc Trans. 1999]J Theor Biol. 1991 Dec 21; 153(4):585-602.
[J Theor Biol. 1991]Biochemistry. 1993 Dec 7; 32(48):13299-309.
[Biochemistry. 1993]J Mol Biol. 2002 Jun 21; 319(5):997-1003.
[J Mol Biol. 2002]J Clin Pharmacol. 1997 Nov; 37(11):991-1000.
[J Clin Pharmacol. 1997]J Am Coll Cardiol. 2002 Nov 20; 40(10):1748-54.
[J Am Coll Cardiol. 2002]